Afsaneh Lavasanifar - Publications

In Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

Journal: Cancer investigation

Published: June 21, 2026

Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer.

Journal: Oncoimmunology

Published: June 02, 2026

Liposomal Delivery of Pyronaridine as a Repurposed Inhibitor of ERCC1/XPF for the Sensitization of Colorectal Cancer Cells to Platinum Chemotherapeutics.

Journal: Molecular pharmaceutics

Published: December 30, 2025

The effect of cryoprotectant and storage conditions on the aggregation of poly(ethylene glycol)-poly(α-benzyl carboxylate-ε-caprolactone) nanoparticles.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: October 10, 2025

Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.

Journal: Biomaterials advances

Published: April 19, 2025

Development, characterization, and in vitro evaluation of poly(ethylene oxide)-block-poly(ε-caprolactone)-α-tocopheryl succinate micelles as a novel nanocarrier for rapamycin delivery.

Journal: International journal of pharmaceutics: X

Published: February 08, 2025

Protein corona composition modulates uptake of polymeric micelles by colorectal cancer cells.

Journal: Nanoscale advances

Published: December 30, 2024

Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics.

Journal: Drug delivery and translational research

Published: December 20, 2024

Immuno-PET Imaging of EGFR with 64Cu-NOTA Panitumumab in Subcutaneous and Metastatic Nonsmall Cell Lung Cancer Xenografts.

Journal: Molecular pharmaceutics

Published: October 15, 2024

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice.

Journal: EJNMMI radiopharmacy and chemistry

Published: August 20, 2024

Personalized treatment approach for HER2-positive metastatic breast cancer.

Journal: Medical oncology (Northwood, London, England)

Published: July 29, 2024

αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment.

Journal: Bioengineering (Basel, Switzerland)

Published: June 30, 2024